Abstract

Navigating the new drug-driving law ● EMA recommends suspension of medicines over trial concerns ● NICE updates approach to biosimilars ● Chondroitin for OA? ● The impact of molluscum contagiosum ● Reassessing treatments for neuropathic pain ● First-line drugs for hypertension ● Stopping smoking and mental health ● Warnings and advice on ▼ valproate treatment